Neuroblastoma in adolescents: The Italian experience

Cancer

Volumn 106, Issue 6, 2006, Pages 1409-1417

  Conte, Massimo ^a   Parodi, Stefano ^a   De Bernardi, Bruno ^a   Milanaccio, Claudia ^a   Mazzocco, Katia ^b   Angelini, Paoia ^a   Viscardi, Elisabetta ^c   Di Cataldo, Andrea ^d   Luksch, Roberto ^e   Haupt, Riccardo ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Adolescents; Clinical course; Neuroblastoma; Survival

Indexed keywords

ADOLESCENT; ADVANCED CANCER; ARTICLE; BONE MARROW METASTASIS; BONE METASTASIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CHILD; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; ONCOGENE MYC; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; ITALY; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NERVOUS SYSTEM NEOPLASMS; NEUROBLASTOMA; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33644847831     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21751     Document Type: Article

References (24)

1. Parkin DM, Whelan SL, Ferlay J, et al., editors. Cancer incidence in five continents, vol VIII. IARC Scientific Publication 155. Lyon: IARC, 2003.
2. Gurney JG, Davis S, Severson RK, et al. Trends in cancer incidence among children in the U.S. Cancer. 1996;78:532-541.
3. De Bernardi B, Nicolas B, Boni L, et al. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Cooperative Group for Neuroblastoma. J Clin Oncol. 2003;21:1592-1601.
4. Rubie H, Coze C, Plantaz D, et al. Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy. Br J Cancer. 2003;89:1605-1609.
5. Valteau-Couanet D, Michon J, Boneu A, et al. Result of induction chemotherapy in children older than 1 year with a Stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol. J Clin Oncol. 2005;23:532-540.
6. Blatt J, Gula MJ, Orlando S, et al. Indolent course of advanced neuroblastoma in children older than six years at diagnosis. Cancer. 1995;75:890-894.
7. Franks LM, Bollen A, Seeger RC, et al. Neuroblastoma in adults and adolescents. Cancer. 1997;79:2028-2035.
8. Lopez R, Karakousis C, Rao U. Treatment of adult neuroblastoma. Cancer. 1980;45:840-844.
9. Kaye JA, Warhol MJ, Kretschmar C, et al. Neuroblastoma in adults. Cancer. 1986;58:1149-1157.
10. Kushner BH, Kramer K, La Quaglia MP, et al. Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience. Med Pediatr Oncol. 2003;41:508-515.
11. Gaspar N, Hartmann O, Munzer C, et al. Neuroblastoma in adolescents. Cancer. 2003;98:349-355.
12. Dosik GM, Rodriguez V, Benjamin RS, et al. Neuroblastoma in adults. Effective combination chemotherapy. Cancer. 1978;41:56-63.
13. Magnani C, Capocaccia R, Giordano L, et al. [Expected number of childhood cancers in Italy, by region.] Riv Ital Pediatr. 1992;18:203-207.
14. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol. 1993;11:1466-1477.
15. Ambros IM, Bernard J, Boavida M, et al. Quality assessment of genetic markers used for therapy stratification. J Clin Oncol. 2003;21:2077-2084.
16. Ambros PF, Ambros IM. Pathology and biology guidelines for respectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol. 2001;37:492-504.
17. Caron H, Van Sluis P, De Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavourable outcome in patients with neuroblastoma. N Engl J Med. 1996;12:225-230.
18. Giaretti W. Ploidy and proliferation evaluated by flow cytometry. An overview of techniques and impact in oncology. Tumori. 1991;77:403-419.
19. Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer. 1999;86:364-372.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
21. Stata Corporation. Stata statistical software: release 7.0. College Station: Stata Corporation, 2001.
22. Cowie F, Corbett R, Pinkerton R. Lung involvement in neuroblastoma: incidence and characteristics. Med Pediatr Oncol. 1997;28:429-432.
23. Xaidara A, Andrioti M, Mikraki V, et al. Neuroblastoma metastatic to brain. Med Pediatr Oncol. 1996;26:208-214.
24. Hickenson MP, Charron M, Maris JM, et al. Biodistribution of post-therapeutic versus diagnostic (131)I-MIBG scans in children with neuroblastoma. Pediatr Blood Cancer. 2004; 42:268-274.